How should type 2 dyssynergic defecation be managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Type 2 Dyssynergic Defecation Management

Biofeedback therapy is the first-line treatment for type 2 dyssynergic defecation, with 70-80% of patients achieving symptom improvement that is sustained for at least 2 years 1, 2.

Understanding Type 2 Dyssynergia

Type 2 dyssynergic defecation involves inadequate propulsive forces (reduced intrarectal pressure rise during straining) combined with paradoxical anal contraction or incomplete relaxation. The goal of biofeedback is to restore normal coordination between abdominal pushing and pelvic floor relaxation, specifically tailored to address the inadequate propulsive component 1.

Diagnostic Confirmation Before Treatment

Before initiating biofeedback, confirm the diagnosis with:

  • Anorectal manometry showing type 2 pattern (inadequate propulsive force + paradoxical contraction)
  • Abnormal balloon expulsion test (inability to expel 50mL balloon)

If these tests are discordant, obtain defecography (fluoroscopic or MRI) to rule out structural pathologies like rectocele or rectal intussusception 1.

Biofeedback Therapy Protocol

Deliver 5-6 biofeedback sessions over 3 months:

  • Sessions last 30-60 minutes
  • Schedule every 2 weeks initially 3
  • Train patients to coordinate abdominal pushing with pelvic floor relaxation
  • For type 2 specifically, emphasize increasing propulsive forces while simultaneously achieving pelvic floor relaxation 1

Who Should Perform Biofeedback

Most commonly performed by pelvic floor physical therapists, though advanced practice nurses or trained registered nurse therapists under appropriate supervision are acceptable 1.

Expected Outcomes and Predictors

Success rates reach 70-80% with biofeedback versus only 22% with laxatives alone 4. The superiority of biofeedback over laxatives is particularly striking in randomized controlled trials, where benefits persist for at least 24 months 4.

Favorable Prognostic Factors:

  • Lower baseline rectal sensory thresholds
  • Shorter colonic transit times
  • Lower bowel satisfaction scores at baseline
  • Use of digital maneuvers to evacuate 1

Poor Prognostic Factors:

  • Depression
  • Elevated first rectal sensory threshold volumes
  • Increased frequency of abdominal pain 1

When Biofeedback Fails

If patients don't respond after an adequate trial (5-6 sessions over 3 months), surgical options are extremely limited and generally not recommended 2. Consider:

  • Reassessment for structural abnormalities
  • Evaluation for coexistent upper GI motility disorders
  • Venting ileostomy or colostomy only in severe refractory cases 2

Botulinum toxin injection and stapled transanal resection cannot be recommended outside clinical trials 2.

Critical Pitfall to Avoid

Do not treat type 2 dyssynergic defecation with laxatives alone—this approach has only 22% success compared to 80% with biofeedback 4. While fiber supplementation (20g/day) and occasional enemas/suppositories may be used initially, patients who don't respond should proceed directly to biofeedback rather than escalating laxative therapy 2, 4.

Algorithm Summary

  1. Confirm diagnosis: ARM showing type 2 pattern + abnormal balloon expulsion
  2. If discordant, obtain defecography
  3. Initiate biofeedback: 5-6 sessions over 3 months with pelvic floor therapist
  4. Tailor training to address inadequate propulsive forces specific to type 2
  5. Assess response at 6 months using symptom scores and repeat balloon expulsion
  6. Continue benefits typically sustained 12-24 months without additional intervention

The evidence strongly supports biofeedback as superior to all other modalities for dyssynergic defecation, with the 2013 AGA guidelines providing a strong recommendation based on high-quality evidence 2.

Related Questions

What is the recommended treatment for dyssynergic defecation (functional constipation)?
I am a male with chronic constipation, difficulty evacuating, pelvic floor heaviness, urinary urgency, and erectile dysfunction; could dyssynergic defecation be the cause and what evaluation and treatment should I pursue?
What foods should be paired with corn to improve bowel movements in a patient with type 2 dyssynergic defecation?
What is the medical term for painful bowel movements?
How should I manage a 50-year-old female with abdominal fullness, bloating, constipation, recent weight gain, moderate fatty liver, bilateral renal calculi, vitamin B12 deficiency, vitamin D deficiency, lumbar spine degenerative disc disease with disc protrusions, and a suspected right lower‑limb deep‑vein thrombosis (DVT) with incompetent saphenopopliteal junction and extensive varicosities?
What is the appropriate management for a patient with scrub typhus presenting with three days of fever, altered mental status, hyperbilirubinemia (bilirubin 17 mg/dL), acute kidney injury (creatinine 2.7 mg/dL) and requiring oxygen support?
In a patient with severe hepatic dysfunction (bilirubin 17 mg/dL) and acute kidney injury (creatinine 2.7 mg/dL), which sedative agent is preferred?
What are the benefits of taking quetiapine 50 mg three times daily versus a 150 mg extended‑release (XR) formulation?
What is the recommended evaluation and management for blisters with pruritus on the feet?
Does electrocution cause bradycardia?
How should postoperative pain, gas, and bloating be managed in a 60-year-old man after hernia repair?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.